SNo Age Sex Cause FVL PT MTHFR Protein C ProteinS AT III APCR LAC Homo- Comorbidity Risk factors screen cystein 1 75 M Arterial 0 0 0 1 1 1 0 1 0 HTN   2 64 M ,, 0 0 0 1 1 1 0 0 1     3 52 F ,, 0 0 0 1 1 1 0 0 0 DM, HTN, CRF   4 78 M ,, 0 0 0 1 1 1 0 0 1 DM, HTN, CVA   5 62 M ,, 0 0 1 1 1 1 0 1 1 CAD Surgery 6 55 M ,, 0 0 0 1 1 1 0 0 0 HTN, CAD   7 63 M ,, 0 0 0 1 1 1 0 0 1 HTN   8 49 M ,, 0 0 0 1 0 1 0 0 0 CAD   9 57 F ,,       1 0 1           10 46 M ,,       1 1 1       DM   11 58 M ,,       1 1 0           12 30 F ,,       1 1 0       DM Past embolism 13 42 M ,,       1 0 1           14 37 M ,,       1 1 0           15 54 F Venous 0 0 1 1 1 1 1 0 0 Hypothyroid   16 62 F ,, 0 0 1 1 1 1 0 1 1 Hypothyroid, HTN   17 60 M ,, 0 0 11 1 1 1 0 0 0 DM   18 49 M ,, 0 0 1 0 0 0 0 0 0     19 42 M ,, 0 0 1 1 0 1 0 1 0   Cirrhosis 20 57 M ,, 0 0 0 0 0 0 0 0 0 HTN   21 52 M ,, 0 0 0 1 1 1 0 0 0 DM Cirrhosis 22 42 M ,, 0 0 1 1 0 1 0 1 1     23 40 F ,,       1 1 1           24 46 M ,,       0 0 1           25 56 M ,,       0 0 0           26 32 M ,,       1 1 1           27 32 M ,,       1 0 0           28 52 F ,,       1 0 0       Hypothyroid   29 25 M ,,       0 0 1

Table 2: Description of abnormalities found on evaluation in each individual patient; *FVL- Factor V Leiden A506G, PT- Prothrombin 20210A, MTHFR- Methylene Tetrahydrofolate Reductase C677T, AT III- Antithrombin III, APCR- Activated protein C resistance, LAC- Lupus anticoagulant screen; 0- Normal test result, 1- Abnormal result (heterozygous mutation in genetic studies), 11- Homozygous mutation DMDiabetes mellitus, HTN- Hypertension, CAD- Coronary artery disease, CVA- Cerebrovascular accident, CRF- Chronic renal failure.